Background: Supplementation of nicotinamide riboside (NR) ameliorates neuropathology in animal models of ataxia telangiectasia (A-T). In humans, short-term NR supplementation showed benefits in neurological outcome.
Objectives: The study aimed to investigate the safety and benefits of long-term NR supplementation in individuals with A-T.